Universal Biosensors Inc (AU:UBI) — Market Cap & Net Worth
Market Cap & Net Worth: Universal Biosensors Inc (UBI)
Universal Biosensors Inc (AU:UBI) has a market capitalization of $2.95 Million (AU$4.17 Million) as of June 21, 2026. Listed on the AU stock exchange, this Australia-based company holds position #29486 globally and #1698 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Universal Biosensors Inc's stock price AU$0.01 by its total outstanding shares 298067435 (298.07 Million). Review Universal Biosensors Inc (UBI) total liabilities to assess the company's total debt and financial obligations.
Universal Biosensors Inc Market Cap History: 2015 to 2026
Universal Biosensors Inc's market capitalization history from 2015 to 2026. Data shows change from $94.91 Million to $2.95 Million (-26.87% CAGR).
Universal Biosensors Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Universal Biosensors Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.52x
Universal Biosensors Inc's market cap is 3.52 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $94.91 Million | $16.77 Million | -$6.58 Million | 5.66x | N/A |
| 2016 | $65.38 Million | $18.83 Million | $1.25 Million | 3.47x | 52.29x |
| 2017 | $63.27 Million | $25.19 Million | -$764.72K | 2.51x | N/A |
| 2018 | $46.40 Million | $69.46 Million | $37.56 Million | 0.67x | 1.24x |
| 2019 | $40.07 Million | $6.90 Million | -$4.85 Million | 5.81x | N/A |
| 2020 | $91.74 Million | $3.20 Million | -$7.67 Million | 28.65x | N/A |
| 2021 | $208.79 Million | $5.78 Million | -$10.30 Million | 36.14x | N/A |
| 2022 | $47.45 Million | $4.52 Million | -$26.85 Million | 10.49x | N/A |
| 2023 | $42.18 Million | $6.63 Million | -$6.74 Million | 6.36x | N/A |
| 2024 | $22.14 Million | $6.28 Million | -$14.24 Million | 3.52x | N/A |
Competitor Companies of UBI by Market Capitalization
Companies near Universal Biosensors Inc in the global market cap rankings as of June 21, 2026.
Key companies related to Universal Biosensors Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
Universal Biosensors Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Universal Biosensors Inc's market cap moved from $94.91 Million to $ 2.95 Million, with a yearly change of -26.87%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$2.95 Million | 0.00% |
| 2025 | AU$2.95 Million | -86.67% |
| 2024 | AU$22.14 Million | -47.50% |
| 2023 | AU$42.18 Million | -11.11% |
| 2022 | AU$47.45 Million | -77.27% |
| 2021 | AU$208.79 Million | +127.59% |
| 2020 | AU$91.74 Million | +128.95% |
| 2019 | AU$40.07 Million | -13.64% |
| 2018 | AU$46.40 Million | -26.67% |
| 2017 | AU$63.27 Million | -3.23% |
| 2016 | AU$65.38 Million | -31.11% |
| 2015 | AU$94.91 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 20th, 2026 the market cap of Universal Biosensors Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.95 Million USD |
| MoneyControl | $2.95 Million USD |
| MarketWatch | $2.95 Million USD |
| marketcap.company | $2.95 Million USD |
| Reuters | $2.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Universal Biosensors Inc
Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of… Read more